Frits S.A.M. van Dam

5.0k total citations · 2 hit papers
33 papers, 3.9k citations indexed

About

Frits S.A.M. van Dam is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Oncology. According to data from OpenAlex, Frits S.A.M. van Dam has authored 33 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 14 papers in Genetics and 8 papers in Oncology. Recurrent topics in Frits S.A.M. van Dam's work include Cancer-related cognitive impairment studies (16 papers), Glioma Diagnosis and Treatment (14 papers) and Brain Metastases and Treatment (10 papers). Frits S.A.M. van Dam is often cited by papers focused on Cancer-related cognitive impairment studies (16 papers), Glioma Diagnosis and Treatment (14 papers) and Brain Metastases and Treatment (10 papers). Frits S.A.M. van Dam collaborates with scholars based in Netherlands, France and United States. Frits S.A.M. van Dam's co-authors include Sanne B. Schagen, Willem Boogerd, Martin J. Muller, Nelly Moerman, Hans Oosting, Martin Müller, Martín Müller, Peter F. Bruning, Elsken van der Wall and Sjoerd Rodenhuis and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer and Pain.

In The Last Decade

Frits S.A.M. van Dam

33 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impairment of Cognitive Function in Women Receiving Adjuvant Treatment for High-Risk Breast Cancer: High-Dose Versus Standard-Dose Chemotherapy

1998 596 citations Frits S.A.M. van Dam, Willem Boogerd et al. profile →
Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma

1999 503 citations Sanne B. Schagen, Frits S.A.M. van Dam et al. Cancer profile →

Peers

Countries citing papers authored by Frits S.A.M. van Dam

Since Specialization

Citations

This map shows the geographic impact of Frits S.A.M. van Dam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frits S.A.M. van Dam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frits S.A.M. van Dam more than expected).

Fields of papers citing papers by Frits S.A.M. van Dam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frits S.A.M. van Dam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frits S.A.M. van Dam. The network helps show where Frits S.A.M. van Dam may publish in the future.

Co-authorship network of co-authors of Frits S.A.M. van Dam

This figure shows the co-authorship network connecting the top 25 collaborators of Frits S.A.M. van Dam. A scholar is included among the top collaborators of Frits S.A.M. van Dam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frits S.A.M. van Dam. Frits S.A.M. van Dam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Late effects of high‐dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging 2011 ·Human Brain Mapping ·Michiel B. de Ruiter, Liesbeth Reneman, Willem Boogerd, Dick J. Veltman, Matthan W.A. Caan, Gwenaëlle Douaud, Cristina Lavini, Sabine C. Linn, Epie Boven, Frits S.A.M. van Dam, Sanne B. Schagen	225
2	Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer 2010 ·Human Brain Mapping ·Michiel B. de Ruiter, Liesbeth Reneman, Willem Boogerd, Dick J. Veltman, Frits S.A.M. van Dam, Aart J. Nederveen, Epie Boven, Sanne B. Schagen	233
3	Constructive Technology Assessment (CTA) as a tool in Coverage with Evidence Development: The case of the 70-gene prognosis signature for breast cancer diagnostics 2009 ·International Journal of Technology Assessment in Health Care ·Valesca P. Retèl, Jolien M. Bueno-de-Mesquita, (unknown), Marc J. van de Vijver, Kirsten F. L. Douma, (unknown), Frits S.A.M. van Dam, C. van Krimpen, (unknown), Rudi M. H. Roumen, Sabine C. Linn, Wim H. van Harten	22
4	Methotrexate reduces hippocampal blood vessel density and activates microglia in rats but does not elevate central cytokine release 2009 ·Behavioural Brain Research ·R. Seigers, (unknown), Harm J. van der Horn, Erik F. J. de Vries, Rudi Dierckx, Lydia Visser, Sanne B. Schagen, Frits S.A.M. van Dam, Jaap M. Koolhaas, Bauke Buwalda	85
5	The influence of priming and pre‐existing knowledge of chemotherapy‐associated cognitive complaints on the reporting of such complaints in breast cancer patients 2008 ·Psycho-Oncology ·Sanne B. Schagen, Enny Das, Frits S.A.M. van Dam	49
6	ERP amplitude and latency in breast cancer survivors treated with adjuvant chemotherapy 2008 ·Clinical Neurophysiology ·Baudewijntje P.C. Kreukels, Hans Hamburger, Michiel B. de Ruiter, Frits S.A.M. van Dam, K. Richard Ridderinkhof, Willem Boogerd, Sanne B. Schagen	44
7	Persistent Neurocognitive Problems After Adjuvant Chemotherapy for Breast Cancer 2008 ·Clinical Breast Cancer ·Baudewijntje P.C. Kreukels, Frits S.A.M. van Dam, K. Richard Ridderinkhof, Willem Boogerd, Sanne B. Schagen	60
8	Effects of High-Dose and Conventional-Dose Adjuvant Chemotherapy on Long-Term Cognitive Sequelae in Patients with Breast Cancer: An Electrophysiologic Study 2006 ·Clinical Breast Cancer ·Baudewijntje P.C. Kreukels, Sanne B. Schagen, K. Richard Ridderinkhof, Willem Boogerd, Hans Hamburger, Martin Müller, Frits S.A.M. van Dam	63
9	Hypnotherapy in radiotherapy patients: A randomized trial 2005 ·International Journal of Radiation OncologyBiologyPhysics ·Lukas J.A. Stalpers, (unknown), (unknown), (unknown), Martin J. Muller, Frits S.A.M. van Dam	38
10	Long-term Results of Olfaction Rehabilitation Using the Nasal Airflow–Inducing ("Polite Yawning") Maneuver After Total Laryngectomy 2002 ·Archives of Otolaryngology - Head and Neck Surgery ·Frans J. M. Hilgers, (unknown), C.J. van As, (unknown), Martin J. Muller, Frits S.A.M. van Dam	41
11	Neurophysiological Evaluation of Late Effects of Adjuvant High-dose Chemotherapy on Cognitive Function 2001 ·Journal of Neuro-Oncology ·Sanne B. Schagen, Hans Hamburger, (unknown), Willem Boogerd, Frits S.A.M. van Dam	106
12	A Pain Monitoring Program for Nurses 2000 ·Journal of Pain and Symptom Management ·(unknown), (unknown), Rianne de Wit, Frits S.A.M. van Dam, Martin J. Muller	96
13	A Pain Monitoring Program for Nurses 2000 ·Journal of Pain and Symptom Management ·(unknown), Rianne de Wit, Frits S.A.M. van Dam, (unknown), (unknown), (unknown)	70
14	A Pain Monitoring Program for nurses: effect on the administration of analgesics 2000 ·Pain ·(unknown), Rianne de Wit, Frits S.A.M. van Dam, Martin J. Muller	46
15	Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma breakdown → 1999 ·Cancer ·Sanne B. Schagen, Frits S.A.M. van Dam, Martín Müller, Willem Boogerd, J. Lindeboom, Peter F. Bruning	503
16	Deterioration of Olfaction and Gustation As a Consequence of Total Laryngectomy 1999 ·The Laryngoscope ·Frits S.A.M. van Dam, Frans J. M. Hilgers, (unknown), (unknown), C.J. van As, Nynke de Jong	49
17	The Amsterdam Preoperative Anxiety and Information Scale (APAIS) 1996 ·Anesthesia & Analgesia ·Nelly Moerman, Frits S.A.M. van Dam, Martin J. Muller, Hans Oosting	428
18	Health-Related Quality-of-Life Evaluation in HIV-Infected Patients 1995 ·PharmacoEconomics ·Josien B. de Boer, Frits S.A.M. van Dam, Mirjam A. G. Sprangers	35
19	The effect of supportive pamidronate treatment on aspects of quality of life of patients with advanced breast cancer 1991 ·European Journal of Cancer and Clinical Oncology ·(unknown), Aeilko H. Zwinderman, Neil K. Aaronson, J. Hermans, (unknown), Frits S.A.M. van Dam, (unknown), O. L. M. Bijvoet, F. J. Cleton	78
20	Pain experience and pain management among hospitalized cancer patients. A clinical study 1989 ·Cancer ·(unknown), Neil K. Aaronson, Frits S.A.M. van Dam	108

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact